Drawing for HH-25

USPTO serial 86516358

HH-25

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
LOOK, JEFFREY J
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HH-25?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas P. Howard

Thomas P. Howard Thomas P. Howard, LLC842 W SOUTH BOULDER ROADSuite 200Louisville, CO 80305

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Chemical additives for use in the manufacture of Organic CBD Oil with a 25:1 CBD:THC ratio; Preservatives for pharmaceutical preparationsACTIVE—
005Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-epileptic pharmaceutical preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of Organic Botanical Oil that facilitate the delivery of pharmaceutical preparations; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal infusions for treating Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Medicinal oils; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of seizures; Pharmaceutical preparations for the treatment and prevention of seizures; Pharmaceutical preparations for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for pediatric patients with status epilepticus; Pharmaceutical preparations, namely, elixirs for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Pharmaceutical products for the prevention and treatment of cancer; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Syringes sold filled with Organic CBD Oil with a 25:1 CBD:THC ratio; Syrups for pharmaceutical purposes for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's DiseaseACTIVE—
040Custom manufacture of Organic CBD Oil with a 25:1 CBD:THC ratio by pharmaceutical compoundersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2015MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Sep 9, 2015ABN1ABANDONMENT - EXPRESS MAILED—
Sep 8, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 8, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 19, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2015DOCKASSIGNED TO EXAMINER—
May 4, 2015DOCKASSIGNED TO EXAMINER—
Feb 7, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Feb 6, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 2, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance